User:Mr. Ibrahem/Crizotinib

Crizotinib, sold under the brand name Xalkori among others, is a medication used to treat non-small cell lung carcinoma (NSCLC). Specifically it is used for advanced disease that is ALK-positive or ROS1-positive. It is taken by mouth.

Common side effects include vision problems, nausea, diarrhea, swelling, liver problems, dizziness, nerve pain, and tiredness. Other side effects may include pneumonitis, low white blood cells, and QT prolongation. Use in pregnancy may harm the baby. It is a receptor tyrosine kinase (RTK) inhibitor.

Crizotinib was approved for medical use in the United States in 2011 and Europe in 2012. In the United Kingdom a month of medication costs the NHS about £4,700 as of 2021. This amount in the United States is about 19,400 USD.